Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 132-139 , June 2007

Radiofrequency Ablation of Renal Tumors

  • Michael J. Stone, MD

      Affiliations

    • Research Fellow, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, Md.
    • ,
  • Aradhana M. Venkatesan, MD

      Affiliations

    • Staff Clinician, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • ,
  • Julia Locklin, RN, MS, CCRC

      Affiliations

    • Research Nurse Specialist, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • ,
  • Peter Pinto, MD

      Affiliations

    • Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
    • ,
  • Marston Linehan, MD

      Affiliations

    • Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.
    • ,
  • Bradford J. Wood, MD

      Affiliations

    • Chief, Interventional Radiology, Diagnostic Radiology Department, National Institutes of Health Clinical Center, Diagnostic Radiology Department, Bethesda, MD.
    • Corresponding Author InformationAddress reprint requests to: Bradford J. Wood, MD, Diagnostic Radiology Department, National Institutes of Health Clinical Center, 1N-264, Department of Diagnostic Radiology, 10 Center Drive MSC 1182, Bethesda, MD 20892.

References 

  1. Laber DA. Risk factors, classification, and staging of renal cell cancer. Med Oncol. 2006;23:443–454
  2. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353–2358
  3. Grimaldi G, Reuter V, Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol. 1998;5:548–552
  4. Siemer S, Uder M, Zell A, et al. Bilateral kidney tumor (Therapy management and histopathological results with long-term follow-up of 66 patients). Urologe A. 2001;40:114–120
  5. Gervais DA, McGovern FJ, Arellano RS. Radiofrequency ablation of renal cell carcinoma: part 1 (Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors). AJR Am J Roentgenol. 2005;185:64–71
  6. Lee SJ, Choyke LT, Locklin JK. Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J Vasc Interv Radiol. 2006;17:1967–1969
  7. Laeseke PF, Sampson LA, Winter TC. Use of dextrose 5% in water instead of saline to protect against inadvertent radiofrequency injuries. AJR Am J Roentgenol. 2005;184:1026–1027
  8. Schultze D, Morris CS, Bhave AD. Radiofrequency ablation of renal transitional cell carcinoma with protective cold saline infusion. J Vasc Interv Radiol. 2003;14:489–492
  9. Berne RM, Levy MN. Physiology. 4th ed.. St. Louis, MO: Mosby; 2007;
  10. Lu DS, Raman SS, Vodopich DJ. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol. 2002;178:47–51
  11. Roarke MC, Collins JM, Nguyen BD. Indolent enterococcal abscess mimicking recurrent renal cell carcinoma on MR imaging and PET/CT after radiofrequency ablation. J Vasc Interv Radiol. 2006;17:1851–1854
  12. Wood BJ, Grippo J, Pavlovich CP. Percutaneous radio frequency ablation for hematuria. J Urol. 2001;166:2303–2304
  13. Janzen NK, Perry KT, Han KR. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol. 2005;173:1368–1374

 This work was supported in part by the Intramural Research Program of the National Institutes of Health.

PII: S1089-2516(07)00087-X

doi: 10.1053/j.tvir.2007.09.011

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 132-139 , June 2007

Article Tools

* Image Usage & Resolution